Yes, but you can’t ignore the financial reports. Despite good revenue growth profitability is lower than 3-4 years ago.
They are investing in growth but little explanation about what forecast is. IMO they have huge potential and are well placed but I have questions about their ability to realise all the upsides in front of them. Agree 4c may be the lower level of their trading range for a while but I remember that level was where they were at in 2020.
I can only see them breaking out if they can land another significant order in next 6 months and start to really ramp up production to be able to deliver multiple orders.
They have a year to get things humming imo or a bunch of others will leave them behind in the market.
- Forums
- ASX - By Stock
- Ann: Product Purchase Orders from i-charging
Yes, but you can’t ignore the financial reports. Despite good...
Featured News
Add RFT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.43M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 0.9¢ | $9.995K | 995K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1533996 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 8283849 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1533996 | 0.009 |
7 | 896000 | 0.008 |
9 | 1332529 | 0.007 |
5 | 1984501 | 0.006 |
3 | 482000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 8283849 | 2 |
0.011 | 4832805 | 1 |
0.012 | 3284620 | 7 |
0.013 | 1155500 | 3 |
0.014 | 70000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RFT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online